In Memoriam: Diane Edmund Griffin, MD, PhD, 1940–2024
Johns Hopkins Bloomberg School of Public HealthDiane Griffin, MD, PhD, a pioneering infectious-disease virologist, scientific leader, and Johns Hopkins professor, died Monday. She was 84.
Diane Griffin, MD, PhD, a pioneering infectious-disease virologist, scientific leader, and Johns Hopkins professor, died Monday. She was 84.
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health sheds light on how the blood-borne parasite that causes African sleeping sickness in humans and related diseases in cattle and other animals establishes long-term infections in hosts. Using a mouse model, the researchers showed thatTrypanosoma brucei essentially plays a game of hide-and-seek by setting up shop in its hosts’ tissues, allowing it to constantly change its protective surface coat and evade antibodies.
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that makers and marketers of prescription opioid painkillers misused scientific evidence to advance five common and inaccurate claims about the safety and effectiveness of prescription opioids—including that they were not addictive.
Joseph Amon, PhD, MSPH, has joined the Johns Hopkins Bloomberg School of Public Health as director of the Center for Public Health and Human Rights. He assumed the role on October 15.
A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.
Nonprofit hospitals in the U.S. received $37.4 billion in tax benefits in 2021, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Carey Business School, and Texas Christian University.
A new report from the Johns Hopkins Center for Gun Violence Solutions underscores the continuing epidemic of gun deaths in the U.S., including among children and especially among Black youth.
Over-the-counter blood pressure measuring devices offer a simple, affordable way for people to track hypertension at home, but the standard arm-size ranges for these devices won’t appropriately fit millions of U.S. consumers, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
Medical debt is significantly more prevalent among adults with depression or anxiety compared to adults without these mental disorders, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. Among adults with depression or anxiety, those with medical debt were twice as likely to report having delayed or forgone mental health care in the previous 12 months compared to those without medical debt.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a new toolkit to guide community efforts for violence prevention.
Philip Anglewicz, PhD, MA, has been named the director of the William H. Gates Sr. Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health. Anglewicz succeeds Jose “Oying” G. Rimon II, who is retiring after serving as the Institute’s director since 2014. Anglewicz assumed his new role July 1.
Experts from the Johns Hopkins Bloomberg School of Public Health are available for interviews to discuss the U.S. Supreme Court’s decision in Moyle v. United States.
An expert from the Johns Hopkins Bloomberg School of Public Health is available for interviews to discuss the U.S. Supreme Court’s decision in Harrington v. Purdue Pharma.
A study led by Johns Hopkins Bloomberg School of Public Health researchers estimates that infant deaths in Texas increased more than expected in the year following the state’s 2021 ban on abortion in early pregnancy, especially among infants with congenital anomalies.